On April 13 2026, Diana Shipping Inc. (DSX) issued an open letter to shareholders of Genco Shipping & Trading Ltd. The letter, dated the same day, urges Genco shareholders to elect six independent director nominees proposed by DSX at Genco’s 2026 annual meeting. DSX currently owns approximately 14.8 % of Genco’s outstanding shares and has offered $23.50 per share in an all‑cash bid backed by $1.433 billion in committed financing.
The letter frames the proposal as a proxy contest designed to overcome Genco’s board defenses. By securing a majority of votes, DSX aims to replace the current board with directors it believes will pursue a strategic consolidation that would combine the two companies’ fleets into a combined 80‑ship operation, strengthening its position in the dry‑bulk market. The six nominees are independent directors with experience in maritime operations and corporate governance.
Genco has responded by reinforcing its defensive posture. The company adopted a poison‑pill shareholder rights plan on October 2 2025, with a 15 % ownership threshold for triggering, although DSX’s letter claims the threshold was lowered to 10 %. Genco also formed a special committee of independent directors and external advisors to review the offer and launched an employee retention plan in February 2026. Genco’s management has criticized the bid as undervaluing the company, lacking an appropriate premium, and carrying execution risks. The company also disputes the valuation of the 16 vessels it plans to sell to Star Bulk Carriers for $470.5 million, calling the prices “fire sale” levels, and notes that its mean analyst NAV is $25.10 per share, higher than the $23.50 offer.
The financing structure is a key element of DSX’s strategy. The $1.433 billion commitment is intended to provide certainty for the transaction, while the sale of 16 Genco vessels to Star Bulk is designed to reduce DSX’s debt exposure and streamline the combined fleet. The deal’s completion hinges on the successful election of the DSX nominees and the resolution of Genco’s objections to the valuation and vessel sale terms.
Management commentary underscores the stakes. Genco CEO John C. Wobensmith stated that the poison‑pill measure was “designed to slow things down” and to ensure any transaction is in the best interests of shareholders. DSX CEO Semiramis Paliou emphasized that the company’s “increased offer … reflects our continued conviction in the financial and strategic merits of the transaction,” and that the proxy contest is a “necessary step to act in the best interest of all shareholders.”
The open letter marks a significant escalation in the takeover battle, potentially reshaping the competitive landscape of the dry‑bulk sector. If DSX succeeds in electing its nominees, the combined entity would command a larger fleet and greater market share, while Genco’s current board would be replaced by directors aligned with DSX’s consolidation strategy. The outcome will influence shareholder value, operational synergies, and the broader market dynamics in the dry‑bulk shipping industry.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.